Cargando…
Radiotherapy after surgery has significant survival benefits for patients with triple‐negative breast cancer
OBJECTIVES: The value of adjuvant radiotherapy for triple‐negative breast cancer (TNBC) has been controversial recently. This study aims to clarify the influence of radiotherapy on the survival of TNBC patients after surgery based on a large population analysis. METHODS: The Surveillance, Epidemiolo...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6382720/ https://www.ncbi.nlm.nih.gov/pubmed/30632300 http://dx.doi.org/10.1002/cam4.1954 |
_version_ | 1783396700990210048 |
---|---|
author | Yao, Yi Chu, Yuxin Xu, Bin Hu, Qinyong Song, Qibin |
author_facet | Yao, Yi Chu, Yuxin Xu, Bin Hu, Qinyong Song, Qibin |
author_sort | Yao, Yi |
collection | PubMed |
description | OBJECTIVES: The value of adjuvant radiotherapy for triple‐negative breast cancer (TNBC) has been controversial recently. This study aims to clarify the influence of radiotherapy on the survival of TNBC patients after surgery based on a large population analysis. METHODS: The Surveillance, Epidemiology, and End Results (SEER) database was exploited to select eligible patients from 2010 to 2014. The categorical variables were examined by chi‐square tests. Breast cancer‐specific survival (BCSS) and overall survival (OS) were compared among patients who received or not received adjuvant radiotherapy after surgery by Kaplan‐Meier method with log‐rank test. Univariate and multivariate survival analysis of BCSS and OS were performed using the Cox proportional hazard model. RESULTS: Totally 22 802 patients were enrolled in this study, of which 10 905 patients received radiotherapy after surgery while 11 897 patients did not receive radiotherapy. Compared with those patients who did not receive radiotherapy, the radiation group had a larger proportion of tumor size <2.0 cm (45.8% vs 38.8%) and chemotherapy (82.5% vs 67.4%). The Kaplan‐Meier plots displayed that patients in the radiation group had better survival than the no radiation group in both BCSS and OS (P < 0.001, respectively). In univariate Cox analysis of BCSS, age 40‐60, married status, white and other race, chemotherapy, radiation, and surgery were associated with better survival (HR < 1, P < 0.05). Specifically, patients who received radiotherapy exhibited better BCSS (HR = 0.52, 95% CI = 0.48‐0.57, P < 0.001). After adjusting for confounding factors by multivariable Cox regression analysis, receipt of radiotherapy was still associated with improved BCSS (HR = 0.79, 95% CI = 0.72‐0.87, P < 0.001). Survival analysis of OS produced similar results. Generally, these data indicate that radiotherapy after surgery has significant survival benefits for the TNBC patients. CONCLUSIONS: This study has confirmed the survival advantage of adjuvant radiotherapy for the TNBC patients. These findings may optimize the current individualized treatment decisions for this patient population. |
format | Online Article Text |
id | pubmed-6382720 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-63827202019-03-01 Radiotherapy after surgery has significant survival benefits for patients with triple‐negative breast cancer Yao, Yi Chu, Yuxin Xu, Bin Hu, Qinyong Song, Qibin Cancer Med Clinical Cancer Research OBJECTIVES: The value of adjuvant radiotherapy for triple‐negative breast cancer (TNBC) has been controversial recently. This study aims to clarify the influence of radiotherapy on the survival of TNBC patients after surgery based on a large population analysis. METHODS: The Surveillance, Epidemiology, and End Results (SEER) database was exploited to select eligible patients from 2010 to 2014. The categorical variables were examined by chi‐square tests. Breast cancer‐specific survival (BCSS) and overall survival (OS) were compared among patients who received or not received adjuvant radiotherapy after surgery by Kaplan‐Meier method with log‐rank test. Univariate and multivariate survival analysis of BCSS and OS were performed using the Cox proportional hazard model. RESULTS: Totally 22 802 patients were enrolled in this study, of which 10 905 patients received radiotherapy after surgery while 11 897 patients did not receive radiotherapy. Compared with those patients who did not receive radiotherapy, the radiation group had a larger proportion of tumor size <2.0 cm (45.8% vs 38.8%) and chemotherapy (82.5% vs 67.4%). The Kaplan‐Meier plots displayed that patients in the radiation group had better survival than the no radiation group in both BCSS and OS (P < 0.001, respectively). In univariate Cox analysis of BCSS, age 40‐60, married status, white and other race, chemotherapy, radiation, and surgery were associated with better survival (HR < 1, P < 0.05). Specifically, patients who received radiotherapy exhibited better BCSS (HR = 0.52, 95% CI = 0.48‐0.57, P < 0.001). After adjusting for confounding factors by multivariable Cox regression analysis, receipt of radiotherapy was still associated with improved BCSS (HR = 0.79, 95% CI = 0.72‐0.87, P < 0.001). Survival analysis of OS produced similar results. Generally, these data indicate that radiotherapy after surgery has significant survival benefits for the TNBC patients. CONCLUSIONS: This study has confirmed the survival advantage of adjuvant radiotherapy for the TNBC patients. These findings may optimize the current individualized treatment decisions for this patient population. John Wiley and Sons Inc. 2019-01-10 /pmc/articles/PMC6382720/ /pubmed/30632300 http://dx.doi.org/10.1002/cam4.1954 Text en © 2019 The Authors. Cancer Medicine published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Clinical Cancer Research Yao, Yi Chu, Yuxin Xu, Bin Hu, Qinyong Song, Qibin Radiotherapy after surgery has significant survival benefits for patients with triple‐negative breast cancer |
title | Radiotherapy after surgery has significant survival benefits for patients with triple‐negative breast cancer |
title_full | Radiotherapy after surgery has significant survival benefits for patients with triple‐negative breast cancer |
title_fullStr | Radiotherapy after surgery has significant survival benefits for patients with triple‐negative breast cancer |
title_full_unstemmed | Radiotherapy after surgery has significant survival benefits for patients with triple‐negative breast cancer |
title_short | Radiotherapy after surgery has significant survival benefits for patients with triple‐negative breast cancer |
title_sort | radiotherapy after surgery has significant survival benefits for patients with triple‐negative breast cancer |
topic | Clinical Cancer Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6382720/ https://www.ncbi.nlm.nih.gov/pubmed/30632300 http://dx.doi.org/10.1002/cam4.1954 |
work_keys_str_mv | AT yaoyi radiotherapyaftersurgeryhassignificantsurvivalbenefitsforpatientswithtriplenegativebreastcancer AT chuyuxin radiotherapyaftersurgeryhassignificantsurvivalbenefitsforpatientswithtriplenegativebreastcancer AT xubin radiotherapyaftersurgeryhassignificantsurvivalbenefitsforpatientswithtriplenegativebreastcancer AT huqinyong radiotherapyaftersurgeryhassignificantsurvivalbenefitsforpatientswithtriplenegativebreastcancer AT songqibin radiotherapyaftersurgeryhassignificantsurvivalbenefitsforpatientswithtriplenegativebreastcancer |